Product Details
Product Name:
Clozapine-d3 |
CAS No.:
1215691-72-7 |
Supply Ability:
10g |
Release date:
2025/04/29 |
Product Introduction
Bioactivity
Name | Clozapine-d3 |
Description | Clozapine-d3 is a deuterated compound of Clozapine. Clozapine has a CAS number of 5786-21-0. Clozapine is a tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries, 10000+ Noval Small Molecucles,16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
CAS:54241-01-9
$1520.00 / 25mg
-
CAS:5786-21-0
$30.00 / 10mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$0.00/1kg |
VIP1Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-05-07 |
|
$0.00/1kg |
VIP1Y
|
Hebei Junhua Import and Export Co., LTD
|
2025-03-24 |
|
$30.00/10mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-05-26 |